Study ID	Patient ID	Sample ID	Patient Current Age	Cancer Type	Cancer Type Detailed	Dosage	Durable Clinical Benefit	Histology	Mean Target Coverage Normal	Mean Target Coverage Tumor	Molecular Smoking Signature	Mutation Count	Neoantigen Burden	Nonsynonymous mutation burden	Oncotree Code	Overall Response	PDL1 Expression	Progress Free Survival (Months)	Progression Free Status	Prior Treatment Of Cytotoxic ChemoTransversion High erapy	Sample Class	Sample Collection Source	Number of Samples Per Patient	Sample Type	Sex	Person Cigarette Smoking History Pack Year Value	Smoking History	Somatic Status	Tissue Source Site	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment Schedule
nsclc_mskcc_2015	AU5884	AU5884	64	Lung cancer	Lung Adenocarcinoma	10	NDB	Adenocarcinoma	70.843604	128.058385	Transversion Low	34	27	34	LUAD	Progression of Disease	Weak	1.8	1:Event	2	Tumor	Frozen	1	Primary	Male	10.0	Former	Matched	Lung	1.13333333333	80	2
nsclc_mskcc_2015	BL3403	BL3403	73	Lung cancer	Lung Adenocarcinoma	10	NDB	Adenocarcinoma	142.309651	178.814652	Transversion Low	143	99	148	LUAD	Stable Response	Weak	6.5	1:Event	1	Tumor	FFPE	1	Met	Female	43.75	Former	Matched	Pleura	4.7	261	2
nsclc_mskcc_2015	CA9903	CA9903	57	Lung cancer	Lung Adenocarcinoma	10	DCB	Adenocarcinoma	71.664856	118.675283	Transversion High	318	226	324	LUAD	Partial Response	Strong	14.5	1:Event	3	Tumor	FFPE	1	Primary	Male	80.0	Former	Matched	Lung	10.5333333333	494	3
nsclc_mskcc_2015	DI6359	DI6359	61	Lung cancer	Lung Adenocarcinoma	10	DCB	Adenocarcinoma	74.122135	154.345326	Transversion High	226	215	228	LUAD	Partial Response	Strong	9.8	0:Censure	6	Tumor	FFPE	1	Met	Female	60.0	Current	Matched	Lymph node	7.53333333333	326	3
nsclc_mskcc_2015	GR4788	GR4788	59	Lung cancer	Lung Squamous Cell Carcinoma	10	NDB	Squamous cell Carcinoma	131.869851	128.244339	Transversion High	165	51	170	LUSC	Progression of Disease	Negative	1.9	1:Event	0	Tumor	Frozen	1	Met	Male	45.0	Current	Matched	Bronchus	5.63333333333	255	2
nsclc_mskcc_2015	HE3202	HE3202	63	Lung cancer	Lung Adenocarcinoma	10	DCB	Adenocarcinoma	89.139081	189.705252	Transversion High	725	610	746	LUAD	Partial Response	Strong	14.7	0:Censure	3	Tumor	FFPE	1	Met	Female	58.0	Former	Matched	Lymph node	24.0333333333	1011	3
nsclc_mskcc_2015	JB112852	JB112852	60	Lung cancer	Lung Adenocarcinoma	10	NDB	Adenocarcinoma	131.38132	198.480088	Transversion Low	182	118	190	LUAD	Progression of Disease	Negative	3.3	1:Event	5	Tumor	FFPE	1	Primary	Male	0.0	Never	Matched	Lung	6.06666666667	341	2
nsclc_mskcc_2015	KA3947	KA3947	64	Lung cancer	Lung Adenocarcinoma	10	DCB	Adenocarcinoma	81.930577	162.673575	Transversion High	296	114	302	LUAD	Stable Response	Strong	8.1	1:Event	0	Tumor	Frozen	1	Met	Female	52.5	Former	Matched	Lymph node	9.8	426	3
nsclc_mskcc_2015	MA7027	MA7027	56	Lung cancer	Lung Adenocarcinoma	10	NDB	Adenocarcinoma	83.373941	129.24121	Transversion High	284	90	292	LUAD	Progression of Disease	Weak	1.8	1:Event	1	Tumor	FFPE	1	Primary	Male	37.5	Former	Matched	Lung	9.36666666667	396	2
nsclc_mskcc_2015	RI1933	RI1933	60	Lung cancer	Lung Adenocarcinoma	10	DCB	Adenocarcinoma	68.188206	164.985052	Transversion High	468	228	473	LUAD	Partial Response	Strong	16.6	0:Censure	1	Tumor	FFPE	1	Met	Female	21.0	Former	Matched	Lymph node	15.5333333333	622	3
nsclc_mskcc_2015	RO3338	RO3338	71	Lung cancer	Lung Adenocarcinoma	10	NDB	Adenocarcinoma	121.010249	126.57824	Transversion Low	105	112	106	LUAD	Progression of Disease	Weak	2.1	1:Event	1	Tumor	FFPE	1	Primary	Male	20.0	Former	Matched	Lung	3.5	167	3
nsclc_mskcc_2015	SC0899	SC0899	64	Lung cancer	Lung Adenocarcinoma	10	DCB	Adenocarcinoma	93.073728	134.579314	Transversion High	291	191	296	LUAD	Partial Response	Weak	12.6	0:Censure	0	Tumor	Frozen	1	Primary	Female	25.0	Current	Matched	Lung	9.66666666667	450	3
nsclc_mskcc_2015	SC6470	SC6470	59	Lung cancer	Lung Adenocarcinoma	10	DCB	Adenocarcinoma	61.39547	144.26427	Transversion High	182	100	185	LUAD	Stable Response	Weak	8.3	1:Event	0	Tumor	Frozen	1	Met	Male	15.0	Current	Matched	Lung	5.96666666667	292	2
nsclc_mskcc_2015	TU0428	TU0428	66	Lung cancer	Lung Adenocarcinoma	10	NDB	Adenocarcinoma	130.048835	113.278032	Transversion High	608	446	626	LUAD	Progression of Disease	Negative	2.1	1:Event	0	Tumor	FFPE	1	Primary	Male	48.0	Current	Matched	Lung	20.2666666667	992	3
nsclc_mskcc_2015	VA1330	VA1330	71	Lung cancer	Lung Adenocarcinoma	10	NDB	Adenocarcinoma	71.166279	125.711679	Transversion Low	42	11	22	LUAD	Stable Response	Unknown	4.1	1:Event	1	Tumor	Frozen	1	Met	Female	0.5	Former	Matched	Lung	1.33333333333	88	3
nsclc_mskcc_2015	VA7859	VA7859	57	Lung cancer	Lung Adenocarcinoma	10	NDB	Adenocarcinoma	70.285595	151.640293	Transversion Low	9	8	11	LUAD	Stable Response	Unknown	6.3	1:Event	1	Tumor	Frozen	1	Met	Female	3.15	Former	Matched	Lung	0.3	45	3